Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Wellgistics Health, Inc. (WGRX : NSDQ)

• Company Description    Wellgistics LLC is a pharmaceutical wholesaler distributor, bridging the gap between small to mid-size pharmaceutical manufacturers and independent retail pharmacies. Wellgistics LLC, formerly known as Danam Health Inc., is based in Tampa, FL. Number of Employees: 7

• Price / Volume Information    Yesterday's Closing Price: $0.08 Daily Weekly Monthly 20 Day Moving Average: 55,072,296 shares Shares Outstanding: 125.67 (millions) Market Capitalization: $10.39 (millions) Beta: -1.17 52 Week High: $2.56 52 Week Low: $0.07 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -39.06% -42.03% 12 Week -64.79% -67.45% Year To Date -79.30% -75.38%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 3000 BAYPORT DRIVE SUITE 950 - TAMPA,FL 33607 USA ph: 844-203-6092 fax: - ir@wellgisticshealth.com http://www.wellgisticshealth.com

• General Corporate Information    Officers Prashant Patel - Chief Executive Officer Eric Sherb - Interim Chief Financial Officer Suren Ajjarapu - Director Prashant Patel - Director Gary Herman - Director Peer Information Wellgistics Health, Inc. (GSAC) Wellgistics Health, Inc. (CASIF) Wellgistics Health, Inc. (ALCD.) Wellgistics Health, Inc. (OMNN) Wellgistics Health, Inc. (CGPI.) Wellgistics Health, Inc. (CATX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-DRUGS Sector: Medical CUSIP: 949503106 SIC: 5122 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/18/26 Share - Related Items Shares Outstanding: 125.67 Most Recent Split Date: (:1) Beta: -1.17 Market Capitalization: $10.39 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/18/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: 0.74 EPS Growth vs. Year Ago Period: 88.71% vs. Previous Quarter: 46.15% Sales Growth vs. Year Ago Period: -85.64% vs. Previous Quarter: -6.64% ROE 03/31/26 - - 12/31/25 - - 09/30/25 - -1,617.25 ROA 03/31/26 - -145.69 12/31/25 - -175.38 09/30/25 - -137.41 Current Ratio 03/31/26 - 0.09 12/31/25 - 0.09 09/30/25 - 0.39 Quick Ratio 03/31/26 - - 12/31/25 - 0.04 09/30/25 - 0.16 Operating Margin 03/31/26 - -434.93 12/31/25 - -367.35 09/30/25 - -224.19 Net Margin 03/31/26 - -545.69 12/31/25 - -433.95 09/30/25 - -228.17 Pre-Tax Margin 03/31/26 - -545.69 12/31/25 - -433.95 09/30/25 - -228.16 Book Value 03/31/26 - -0.12 12/31/25 - -0.14 09/30/25 - 0.08 Inventory Turnover 03/31/26 - 4.22 12/31/25 - 4.27 09/30/25 - 3.51 Debt-to-Equity 03/31/26 - - 12/31/25 - - 09/30/25 - 1.86 Debt-to-Capital 03/31/26 - - 12/31/25 - - 09/30/25 - 65.02

Powered by Zacks Investment Research ©